Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens

Journal of Cancer Research and Clinical Oncology

Volumn 126, Issue 4, 2000, Pages 226-232

  Menssen, H D ^a   Bertelmann, E ^a   Bartelt, S ^a   Schmidt, R A ^a   Pecher, G ^a   Schramm, K ^a   Thiel, E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cancer cell lines; Cancer specimen; Colon cancer; Glioblastoma; Lung cancer; Wilms' tumor gene expression

Indexed keywords

ARTICLE; CARCINOGENESIS; CELL GROWTH; COLON CANCER; CONTROLLED STUDY; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; LUNG CANCER; NEPHROBLASTOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034073192     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050037     Document Type: Article

References (41)

1. Algar EM, Khromykh T, Smith SI, Blackburn DM, Bryson GJ, Smith PJ (1996) A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Oncogene 12:1005-1014
2. Amin KM, Litzky LA, Smythe WR, Mooney AM, Morris JM, Mews DJ, Pass HI, Kari C, Rodeck U, Rauscher FJ 3rd et al (1995) Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am J Pathol 146:344-356
3. Augeron C, Laboisse CL (1984) Emergence of permanently differentiated cell clones in a human colonie cancer cell line in culture after treatment with sodium butyrate. Cancer Res 44:3961-3969
4. Barnard JA, Warwick G (1993) Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ 4:495-501
5. Bergmann L, Miething C, Maurer U, Brieger J, Karakas T, Weidmann E, Hoelzer D (1997) High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 90:1217-1225
6. Brieger J, Weidmann E, Fenchel K, Mitrou PS, Hoelzer D, Bergmann L (1994) The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells. Leukemia 8:2138-2143
7. Brieger J, Weidmann E, Maurer U, Hoelzer D, Mitrou PS, Bergmann L (1995) The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR. Ann Oncol 6:811-816
8. Bruening W, Gros P, Sato T, Stanimir J, Nakamura Y, Housman D, Pelletier J (1993) Analysis of the 11p13 Wilms' tumor suppressor gene (WT1) in ovarian tumors. Cancer Invest 11:393-399
9. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housmann DE (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509-520
10. Campbell CE, Kuriyan NP, Rackley RR, Caulfield MJ, Tubbs R, Finke J, Williams BR (1998) Constitutive expression of the Wilms' tumor suppressor gene (WT1) in renal cell carcinoma. Int J Cancer 78:182-188
11. Gazdar AF, Carney DN, Nau MM, Minna JD (1985) Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinct biochemical, morphological and growth properties. Cancer Res 45:2924-2930
12. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP (1990) Homozygous deletions in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774-778
13. Hodin RA, Meng S, Archer S, Tang R (1996) Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells. Cell growth and differentiation 7:647-653
14. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K, et al (1994) WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84:3071-3079
15. Inoue K, Ogawa H, Yamagami T, Soma T, Tani Y, Tatekawa T, Oji Y, Tamaki H, Kyo T, Dohy H, Hiraoka A, Masaoka T, Kishimoto T, Sugiyama H (1996) Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels. Blood 88:2267-2278
16. Inoue K, Ogawa H, Sonoda Y, Kimura T, Sakabe H, Oka Y, Miyake S, Tamaki H, Oji Y, Yamagami T, Tatekawa T, Soma T, Kishimoto T, Sugiyama H (1997) Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood 89:1405-1412
17. Kumar-Singh S, Segers K, Rodeck U, Backhovens H, Bogers J, Weyler J, Van Broeckhoven C, Van Marck E (1997) WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis. J Pathol 181:67-74
18. Ladanyi M, Gerald W (1994) Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 54:2837-2840
19. Langerak AW, Williamson KA, Miyagawa K, Hagemeijer A, Versnel MA, Hastie ND (1995) Expression of the Wilms' tumor gene WT1 in human malignant mesothelioma cell lines and relationship to platelet-derived growth factor A and insulin-like growth factor 2 expression. Genes Chromosomes Cancer 12:87-96
20. Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD (1983) Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306:194-196
21. Maheswaran S, Park S, Bernard A, Morris JF, Rauscher FJd, Hill DE, Haber DA (1993) Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci USA 90:5100-5104
22. Menke AL, Shvarts A, Riteco N, Ham RCA van, Eb AJG van der (1997) Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor. Cancer Res 57:1353-1363
23. Menssen HD, Renkl HJ, Rodeck U, Maurer J, Notter M, Schwartz S, Reinhardt R, Thiel E (1995) Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia 9:1060-1067
24. Menssen HD, Renkl H-J, Entezami M, Thiel E (1997a) Wilms' tumor gene expression in human CD34+ hematopoietic progenitors during fetal development and early growth (letter). Blood 89:3486-3487
25. Menssen HD, Renkl HJ, Rodeck U, Kari C, Schwartz S, Thiel E (1997b) Detection by monoclonal antibodies of the Wilms' tumor (WT1) nuclear protein in patients with acute leukemia. Int J Cancer 70:518-523
26. Menssen HD, Renkl HJ, Rieder H, Bartelt S, Schmidt A, Notter M, Thiel E (1998) Distinction of eosinophilic leukaemia from idiopathic hypereosinophilic syndrome by analysis of Wilms' tumor gene expression. Br J Haematol 101:325-334
27. Miwa H, Beran M, Saunders GF (1992) Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia 6:405-409
28. Miyagi T, Ahuja H, Kubota T, Kubonishi I, Koeffler HP, Miyoshi I (1993) Expression of the candidate Wilms' tumor gene, WT1, in human leukemia cells. Leukemia 7:970-977
29. Nagel WW, Vallee BL (1995) Cell cycle regulation of metallothionein in human colonic cancer cells. Proc Natl Acad Sci 92:579-583
30. Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EH, Soma T, Tatekawa T, Kawakami M, Asada M, Kishimoto T, Sugiyama H (1999) Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res 90:194-204
31. Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Roberts D, Fletcher J, Shipman R, Rheinwald J, Demetri G, et al (1993) The Wilms tumor gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nat Genet 4:415-420
32. Phelan SA, Lindberg C, Call KM (1994) Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells. Cell Growth Differ 5:677-686
33. Rauscher FJ 3rd, Morris JF, Fredericks WJ, Lopez-Guisa J, Balakrishnan C, Jost M, Herlyn M, Rodeck U (1998) Characterization of monoclonal antibodies directed to the amino-terminus of the WT1. Wilms' tumor suppressor protein. Hybridoma 17:191-198
34. Rodeck U, Bossier A, Kari C, Humphreys CW, Gyorfi T, Maurer J, Thiel E, Menssen HD (1994) Expression of the wt1 Wilms' tumor gene by normal and malignant human melanocytes. Int J Cancer 59:78-82
35. Rose EA, Glaser T, Jones C, Smith CL, Lewis WH, Call KM, Minden M, Champagne E, Yeger H, Housemann DE (1990) Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene. Cell 60:495-510
36. Sekiya M, Adachi M, Hinoda Y, Imai K, Yachi A (1994) Down-regulation of Wilms' tumor gene (wt1) during myelomonocytic differentiation in HL60 cells. Blood 83:1876-1882
37. Silberstein GB, Van Horn K, Strickland P, Roberts CT Jr, Daniel CW (1997) Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer. Proc Natl Acad Sci USA 94:8132-8137
38. Tanaka Y, Bush KK, Klauck KM, Higgins PJ (1989) Enhancement of Butyrate-induced differentiation of the HT-29 human carcinoma cells by 1,25-dihydroxyvitamin D3. Biochem Pharmacol 38:3859-3865
39. Viel A, Giannini F, Capozzi E, Canzonieri V, Scarabelli C, Gloghini A, Boiocchi M (1994) Molecular mechanisms possibly affecting WT1 function in human ovarian tumors. Int J Cancer 57:515-521
40. Walker C, Rutten F, Yuan X, Pass H, Mew DM, Everitt J (1994) Wilms' tumor suppressor gene expression in rat and human mesothelioma. Cancer Res 54:3101-3106
41. Yamagami T, Sugiyama H, Inoue K, Ogawa H, Tatekawa T, Hirata M, Kudoh T, Akiyama T, Murakami A, Maekawa T (1996) Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood 87:2878-2884